Pertuzumab and Trastuzumab with or Without Metronomic Chemotherapy for Older Patients with Her2-Positive Metastatic Breast Cancer: Results from the Eortc 75111-10114 Etf/Bcg Randomized Phase Ii Study
AuthID
P-00N-NQP
P-00N-NQP